BASF is reorganizing its Nutrition & Health business unit and combining its activities in the global Nutrition Ingredients business unit. In addition, the feed enzymes business is to be further expanded.
BASF's Nutrition & Health division is strengthening its position as a leading manufacturer of ingredients for the animal and human nutrition industries by combining strategic and operational responsibility for these areas in a global business unit 'Nutrition Ingredients'. The new unit will promote core product platforms for vitamins and carotenoids, which are deeply integrated into the BASF Verbund. It will also further expand the feed enzymes business.
BASF has already completed the expansion of a vitamin A plant at its Ludwigshafen site in 2021 to increase the supply of vitamin A in the market. This will now be followed by an expansion of the world-scale plant for the formulation of vitamin A powder for animal nutrition, with startup planned for mid-2023. In addition, BASF expanded the production capacity for feed enzymes in Ludwigshafen in January 2022. This will enable BASF to meet the increasing demand for enzymes and thus accompany the growth plans of its customers in the feed industry.
New strategic options are currently being evaluated for the "Food and Health Performance Ingredients" portfolio, the statement added. However, the evaluation will have no impact on production in Illertissen or on the company's ability to deliver and its obligations to customers. The "Aroma Ingredients" business unit will be further developed into a global business unit. The headquarters of the Aroma Ingredients business unit will be relocated to Singapore to ensure proximity to key growth markets in Asia. The headquarters of "Pharma Solutions" will remain in the United States, according to BASF.